Erica and Whitney

Erica (age 20) and Whitney (age 16) are two charming young women each of whom have been diagnosed with high risk medulloblastoma.  Again, the gene- chipping and FISH technologies were used to aid the diagnosis of their cancers and it was determined that they needed treatment options beyond the “standard protocol.”  They were both given chemotherapy in additional to their radiation treatment regimen.

The potential for remarkably improved outcomes for both these young women can be directly linked to their doctors’ ability to understand the genetic composition of their particular tumors.